Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages
February 26, 2021
On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have again been extended by one month.
Stocks of medicinal products used to treat COVID-19 patients have been closely monitored by the FAMHP since the onset of the COVID-19 crisis.
As of 1 April 2020, the FAMHP has drawn up a list of medicinal products and raw materials used in the treatment of COVID-19 for which emergency measures have been taken. These measures have then been refined and extended. Since mid-June 2020, these are mainly measures relating to quotas for wholesalers.